Related Experiment Video
Updated: May 16, 2026
Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
Ex vivo differentiation of cord blood stem cells into megakaryocytes and platelets
Nicolas Pineault1, Amélie Robert, Valérie Cortin
1Département de Recherche et Développement, Héma-Québec, Université Laval, Québec City, QC, Canada. nicolas.pineault@hema-quebec.qc.ca
Abstract:
Megakaryocytes (MK) are hematopoietic cells present in the bone marrow that are responsible for the production and release of platelets in the circulation. Given their very low frequency (<1%), human MK often need to be derived in culture to study their development or to generate sufficient material for biological studies. This chapter describes a simplified 14-day culture protocol that efficiently leads to the production of MK and platelets from cord blood enriched progenitor cells. A serum-free medium is suggested for the growth of the CB cells together with an optimized cytokine cocktail developed specifically for MK differentiation, expansion, and maturation. Methodologies for flow cytometry analysis, MK and platelets estimation, and MK progenitor assay are also presented.
Insights
This study presents a 14-day protocol for generating megakaryocytes (MK) and platelets from cord blood progenitor cells. The serum-free method uses an optimized cytokine cocktail for efficient cell production and analysis.
Area of Science:
- Hematology
- Cell Biology
- Stem Cell Research
Background:
- Megakaryocytes (MK) are crucial for platelet production but are rare in bone marrow.
- In vitro culture is often necessary for studying human MK development and function.
- Existing methods can be complex and time-consuming.
Purpose of the Study:
- To describe a simplified 14-day culture protocol for efficient MK and platelet production.
- To optimize conditions for MK differentiation, expansion, and maturation from cord blood progenitors.
- To present methodologies for MK and platelet analysis.
Main Methods:
- Utilized cord blood enriched progenitor cells.
- Employed a serum-free culture medium.
- Incorporated an optimized cytokine cocktail for MK development.
- Included flow cytometry and progenitor assays for analysis.
Main Results:
- Achieved efficient production of MK and platelets within 14 days.
- Demonstrated successful MK differentiation, expansion, and maturation.
- Established reliable methods for cell quantification and progenitor assessment.
Conclusions:
- The described protocol offers a simplified and efficient method for generating human MK and platelets in vitro.
- This approach facilitates further research into MK biology and platelet generation.
- The optimized culture system supports robust MK development from cord blood progenitors.
